Journal article icon

Journal article

Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature

Abstract:
Background
Appropriate treatment and management of children presenting with fever depend on accurate and timely diagnosis, but current diagnostic tests lack sensitivity and specificity and are frequently too slow to inform initial treatment. As an alternative to pathogen detection, host gene expression signatures in blood have shown promise in discriminating several infectious and inflammatory diseases in a dichotomous manner. However, differential diagnosis requires simultaneous consideration of multiple diseases. Here, we show that diverse infectious and inflammatory diseases can be discriminated by the expression levels of a single panel of genes in blood.
Methods
A multi-class supervised machine-learning approach, incorporating clinical consequence of misdiagnosis as a “cost” weighting, was applied to a whole-blood transcriptomic microarray dataset, incorporating 12 publicly available datasets, including 1,212 children with 18 infectious or inflammatory diseases. The transcriptional panel identified was further validated in a new RNA sequencing dataset comprising 411 febrile children.
Findings
We identified 161 transcripts that classified patients into 18 disease categories, reflecting individual causative pathogen and specific disease, as well as reliable prediction of broad classes comprising bacterial infection, viral infection, malaria, tuberculosis, or inflammatory disease. The transcriptional panel was validated in an independent cohort and benchmarked against existing dichotomous RNA signatures.
Conclusions
Our data suggest that classification of febrile illness can be achieved with a single blood sample and opens the way for a new approach for clinical diagnosis. Funding
European Union’s Seventh Framework no. 279185; Horizon2020 no. 668303 PERFORM; Wellcome Trust (206508/Z/17/Z); Medical Research Foundation (MRF-160-0008-ELP-KAFO-C0801); NIHR Imperial BRC.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/j.medj.2023.06.007

Authors

Contributors

Role:
Contributor
Role:
Contributor
Role:
Contributor



Publisher:
Cell Press
Journal:
Med More from this journal
Volume:
4
Issue:
9
Pages:
P635-654.E5
Place of publication:
United States
Publication date:
2023-08-11
Acceptance date:
2023-06-19
DOI:
EISSN:
2666-6340
ISSN:
2666-6359
Pmid:
37597512


Language:
English
Keywords:
Pubs id:
1514637
Local pid:
pubs:1514637
Deposit date:
2023-09-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP